D. Scott Neal Inc. Takes $262,000 Position in Oracle Corporation $ORCL

Key Points

• D. Scott Neal Inc. has acquired a new position in Oracle Corporation with an investment of approximately $262,000 for 1,200 shares during the second quarter.
• Insider transactions at Oracle include Clayton M. Magouyrk selling 15,000 shares for over $3.2 million, while Director Rona Alison Fairhead bought 480 shares valued at over $112,000.
• Oracle recently announced a quarterly dividend of $0.50 per share, set to be paid on October 23rd, representing an annualized dividend yield of 0.7%.

D. Scott Neal Inc. purchased a new position in Oracle Corporation (NYSE:ORCL - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,200 shares of the enterprise software provider's stock, valued at approximately $262,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Vanguard Group Inc. grew its holdings in shares of Oracle by 2.2% during the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock valued at $22,498,982,000 after buying an additional 3,513,464 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Oracle by 0.6% during the first quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider's stock valued at $2,760,048,000 after buying an additional 120,889 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Oracle by 0.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider's stock valued at $1,941,195,000 after buying an additional 59,164 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Oracle by 20.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after buying an additional 2,350,448 shares during the last quarter. Finally, Amundi grew its holdings in shares of Oracle by 3.3% during the first quarter. Amundi now owns 12,736,855 shares of the enterprise software provider's stock valued at $1,749,280,000 after buying an additional 409,691 shares during the last quarter. Institutional investors own 42.44% of the company's stock.

Insider Transactions at Oracle

In related news, insider Clayton M. Magouyrk sold 15,000 shares of the stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total transaction of $3,211,500.00. Following the completion of the sale, the insider owned 60,722 shares of the company's stock, valued at $13,000,580.20. This represents a 19.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Rona Alison Fairhead bought 480 shares of the firm's stock in a transaction that occurred on Monday, July 7th. The shares were purchased at an average cost of $233.87 per share, with a total value of $112,257.60. Following the transaction, the director directly owned 22,110 shares of the company's stock, valued at $5,170,865.70. The trade was a 2.22% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have sold 44,183 shares of company stock worth $10,353,198. Insiders own 42.20% of the company's stock.

Oracle Stock Performance

Shares of NYSE:ORCL opened at $292.07 on Monday. The company has a market capitalization of $829.98 billion, a price-to-earnings ratio of 67.61, a PEG ratio of 3.16 and a beta of 1.46. Oracle Corporation has a 12 month low of $118.86 and a 12 month high of $345.72. The firm's 50-day moving average is $244.69 and its 200 day moving average is $190.68. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle's dividend payout ratio is presently 46.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Piper Sandler raised their target price on shares of Oracle from $270.00 to $330.00 and gave the stock an "overweight" rating in a report on Wednesday, September 10th. UBS Group set a $300.00 target price on shares of Oracle in a report on Wednesday. JMP Securities raised their target price on shares of Oracle from $315.00 to $342.00 and gave the stock a "market outperform" rating in a report on Wednesday, September 10th. Barclays raised their target price on shares of Oracle from $221.00 to $281.00 and gave the stock an "overweight" rating in a report on Monday, September 8th. Finally, Jefferies Financial Group lifted their price target on shares of Oracle from $270.00 to $360.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $296.84.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.